Syndax Pharmaceuticals PEG Ratio

Syndax Pharmaceuticals (SNDX) currently reports a PEG ratio of 14.95. That is above the Healthcare sector average of 11.05. Use the charts on this page to explore Syndax Pharmaceuticals's PEG ratio history and peer comparisons.

Syndax Pharmaceuticals's PEG ratio of 14.95 is higher than the Healthcare sector average of 11.05. That is roughly 35.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Syndax Pharmaceuticals's market price to a fundamental measure such as earnings, sales, or book value. At 14.95, SNDX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 14.95, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.05. From there, open related valuation or income-statement pages for Syndax Pharmaceuticals, and consider following SNDX for alerts when major investors trade the stock.

Syndax Pharmaceuticals is classified in the Healthcare sector. On PEG ratio, it currently shows 14.95 versus a sector average near 11.05. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNDX with unrelated industries.